A study finds firefighters have a 62% higher risk of developing esophageal cancer compared to the general population. There's ...

Esophageal cancer is relatively rare, making up only 1% of all cancer diagnoses in the US. However, it is also one of the most deadly cancers — with a five-year survival rate of only 20%.

Virginia congressman, Gerry Connolly, died at 75 following a battle with esophageal cancer. Here's what it is. Skip Navigation. Share on Facebook; ... What are the symptoms of esophageal cancer?

Providence St. Jude Medical Center is the first to partner with a fire department to conduct the test with every firefighter ...

Jack Georgakis, diagnosed with aggressive gastroesophageal junction cancer, recovered through a groundbreaking treatment ...

Esophageal cancer usually does not cause symptoms in the early stages, which means it is often not caught until advanced stages when it is more difficult to treat. Typical signs of this condition ...

Esophageal cancer often develops silently, with noticeable symptoms appearing only after the disease has advanced. This delayed symptom onset contributes significantly to the disease’s poor ...

Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, ... April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs ...

Learn what GERD is, its causes, symptoms, and why some cases are hard to treat, even with ... Complex GERD – This includes serious conditions like Barrett’s esophagus or even esophageal cancer.

CURE sat down with Dezfoli to discuss how the noninvasive EsoGuard test could expand access to screening for Barrett’s esophagus and help prevent esophageal cancer. Dezfoli is a gastroenterologist and ...

Geoffrey Y. Ku, MD: I definitely agree it's a little bit of a niche topic here in the US, because numerically, we probably see 4000-5000 patients with esophageal squamous cell cancer every year ...

In patients with inoperable locally advanced esophageal cancer who received definitive concurrent chemoradiotherapy, a higher radiation dose (≥ 59.4 Gy) did not improve survival compared with ...